TRVI - Trevi Therapeutics Inc. (TRVI) Q1 2024 Earnings Call Transcript
2024-05-11 13:56:10 ET
Trevi Therapeutics, Inc. (TRVI)
Q1 2024 Earnings Conference Call
May 7, 2024 4:30 PM ET
Company Participants
Jennifer Good - President and Chief Executive Officer
Lisa Delfini - Chief Financial Officer
David Clark - Chief Medical Officer
Conference Call Participants
Leland Gershell - Oppenheimer
Jack Padovano - Stifel
Nathanael Charoensook - Leerink Partners
Mayank Mamtani - B. Riley Securities
Presentation
Operator
Good afternoon, and welcome to the Trevi Therapeutics First Quarter 2024 Earnings Conference Call. At this time, all participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent quarterly report on Form 10-Q, which the company filed with the SEC this afternoon....
Trevi Therapeutics, Inc. (TRVI) Q1 2024 Earnings Call Transcript